Spine Injury clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the safety of cross sequential escalating doses of AST-OPC1 administered among 5 cohorts at a single time-point between 21 and 42 days post injury, inclusively, to subjects with subacute cervical spinal cord injuries (SCI).
La Jolla, California and other locations